moxalactam has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, SP; Markowitz, SM | 1 |
| Buccini, F; Cherubin, C; Eng, RH; Smith, SM | 1 |
| Aziz, MT; Kumar, A | 1 |
| Canawati, HN; Gilmore, DS; Montgomerie, JZ; Morrow, JW | 1 |
1 trial(s) available for moxalactam and Recrudescence
| Article | Year |
|---|---|
Ceftazidime in treatment of urinary tract infection in patients with spinal cord injury: comparison with moxalactam.
Topics: Adult; Ceftazidime; Humans; Male; Moxalactam; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Spinal Cord Injuries; Urinary Tract Infections | 1990 |
3 other study(ies) available for moxalactam and Recrudescence
| Article | Year |
|---|---|
Failure of moxalactam in the treatment of neonatal sepsis and meningitis from Salmonella typhimurium.
Topics: Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Meningitis; Moxalactam; Recurrence; Salmonella Infections; Salmonella typhimurium; Sepsis | 1983 |
Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.
Topics: Aged; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis; Microbial Sensitivity Tests; Moxalactam; Recurrence; Salmonella Infections | 1984 |
Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Cerebral Ventricles; Encephalitis; Escherichia coli Infections; Humans; Infant; Male; Meningitis; Moxalactam; Recurrence | 1981 |